Ok‐Hee Jeon

1.2k total citations
25 papers, 892 citations indexed

About

Ok‐Hee Jeon is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Ok‐Hee Jeon has authored 25 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Genetics and 10 papers in Cancer Research. Recurrent topics in Ok‐Hee Jeon's work include Protease and Inhibitor Mechanisms (10 papers), Venomous Animal Envenomation and Studies (7 papers) and Bioactive Natural Diterpenoids Research (4 papers). Ok‐Hee Jeon is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), Venomous Animal Envenomation and Studies (7 papers) and Bioactive Natural Diterpenoids Research (4 papers). Ok‐Hee Jeon collaborates with scholars based in South Korea and United States. Ok‐Hee Jeon's co-authors include Doo‐Sik Kim, Jonathan Pevsner, SakkuBai Naidu, Mary E. Blue, Michael V. Johnston, Younghee Lee, Hyung‐Joo Kwon, Keunwook Lee, Dong Seok Kim and Karim Hyder and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Ok‐Hee Jeon

25 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ok‐Hee Jeon South Korea 17 466 360 164 143 111 25 892
Jakob V. Nielsen Denmark 14 372 0.8× 151 0.4× 79 0.5× 46 0.3× 85 0.8× 18 798
Chaim Jalas United States 23 724 1.6× 375 1.0× 67 0.4× 33 0.2× 99 0.9× 60 1.7k
Minh Vu Chuong Nguyen France 16 406 0.9× 239 0.7× 64 0.4× 134 0.9× 188 1.7× 28 818
Christine Schröder Germany 19 370 0.8× 70 0.2× 102 0.6× 133 0.9× 208 1.9× 25 1.0k
Timothy M. Stearns United States 19 442 0.9× 148 0.4× 127 0.8× 12 0.1× 199 1.8× 51 1.0k
Jerzy Bal Poland 19 486 1.0× 244 0.7× 24 0.1× 54 0.4× 111 1.0× 113 1.1k
Martin Hergersberg Switzerland 16 785 1.7× 435 1.2× 26 0.2× 38 0.3× 56 0.5× 35 1.4k
Anne Oberson Switzerland 11 522 1.1× 151 0.4× 69 0.4× 17 0.1× 169 1.5× 18 925
Shaoping Xie United Kingdom 17 874 1.9× 229 0.6× 173 1.1× 10 0.1× 206 1.9× 20 1.4k

Countries citing papers authored by Ok‐Hee Jeon

Since Specialization
Citations

This map shows the geographic impact of Ok‐Hee Jeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ok‐Hee Jeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ok‐Hee Jeon more than expected).

Fields of papers citing papers by Ok‐Hee Jeon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ok‐Hee Jeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ok‐Hee Jeon. The network helps show where Ok‐Hee Jeon may publish in the future.

Co-authorship network of co-authors of Ok‐Hee Jeon

This figure shows the co-authorship network connecting the top 25 collaborators of Ok‐Hee Jeon. A scholar is included among the top collaborators of Ok‐Hee Jeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ok‐Hee Jeon. Ok‐Hee Jeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeon, Ok‐Hee, et al.. (2023). Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint. Medicina. 59(4). 725–725. 1 indexed citations
2.
Kim, Darae, Jung‐Jae Lee, Yong‐Joon Lee, et al.. (2022). Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling. BMC Medicine. 20(1). 309–309. 36 indexed citations
3.
Lee, Seung‐Jun, Jung‐Sun Kim, Oh‐Hyun Lee, et al.. (2020). Anti-Inflammatory Effect for Atherosclerosis Progression by Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor in a Normoglycemic Rabbit Model. Korean Circulation Journal. 50(5). 443–443. 55 indexed citations
4.
Koo, B.-S., et al.. (2009). Membrane type‐1 matrix metalloprotease‐independent activation of pro‐matrix metalloprotease‐2 by proprotein convertases. FEBS Journal. 276(21). 6271–6284. 5 indexed citations
5.
Koo, B.-S., et al.. (2009). Regulatory Mechanism of Matrix Metalloprotease-2 Enzymatic Activity by Factor Xa and Thrombin. Journal of Biological Chemistry. 284(35). 23375–23385. 20 indexed citations
6.
Jeon, Ok‐Hee, et al.. (2008). MMP-2 regulates human platelet activation by interacting with integrin αIIbβ3. Journal of Thrombosis and Haemostasis. 6(3). 517–523. 34 indexed citations
7.
Kim, Dong Seok, Ok‐Hee Jeon, Heedoo Lee, Kyung Ho Yoo, & Doo‐Sik Kim. (2008). Integrin αvβ3-mediated transcriptional regulation of TIMP-1 in a human ovarian cancer cell line. Biochemical and Biophysical Research Communications. 377(2). 479–483. 11 indexed citations
8.
Jeon, Ok‐Hee, et al.. (2007). Saxatilin, a Snake Venom Disintegrin, Regulates Platelet Activation Associated with Human Vascular Endothelial Cell Migration and Invasion. Journal of Vascular Research. 44(2). 129–137. 11 indexed citations
10.
Park, Su Jeong, et al.. (2007). Apolipoprotein E genotyping by multiplex tetra-primer amplification refractory mutation system PCR in single reaction tube. Journal of Biotechnology. 131(2). 106–110. 34 indexed citations
11.
Kim, Dong-Seok, et al.. (2007). Saxatilin Suppresses Tumor-induced Angiogenesis by Regulating VEGF Expression in NCI-H460 Human Lung Cancer Cells. BMB Reports. 40(3). 439–443. 35 indexed citations
12.
Jeon, Ok‐Hee, et al.. (2006). Novel function of human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation. Thrombosis Research. 119(5). 609–619. 6 indexed citations
13.
Kim, Dong Seok, et al.. (2006). Saxatilin inhibits TNF-α-induced proliferation by suppressing AP-1-dependent IL-8 expression in the ovarian cancer cell line MDAH 2774. Molecular Immunology. 44(6). 1409–1416. 17 indexed citations
14.
Lee, Keunwook, Wern‐Joo Sohn, Younghee Lee, et al.. (2006). Regulation of matrix metalloproteinase-9 gene expression and cell migration by NF-κB in response to CpG-oligodeoxynucleotides in RAW 264.7 cells. Molecular Immunology. 44(6). 1393–1400. 45 indexed citations
15.
You, Weon‐Kyoo, et al.. (2005). Functional roles of the two distinct domains of halysase, a snake venom metalloprotease, to inhibit human platelet aggregation. Biochemical and Biophysical Research Communications. 339(3). 964–970. 17 indexed citations
16.
Johnston, Michael V., Ok‐Hee Jeon, Jonathan Pevsner, Mary E. Blue, & SakkuBai Naidu. (2001). Neurobiology of Rett syndrome: a genetic disorder of synapse development. Brain and Development. 23. S206–S213. 96 indexed citations
17.
Jeon, Ok‐Hee, et al.. (2001). The Abnormal Regulation of Gene Expression in Autistic Brain Tissue. Journal of Autism and Developmental Disorders. 31(6). 545–549. 16 indexed citations
18.
Colantuoni, Carlo, Ok‐Hee Jeon, Karim Hyder, et al.. (2001). Gene Expression Profiling in Postmortem Rett Syndrome Brain: Differential Gene Expression and Patient Classification. Neurobiology of Disease. 8(5). 847–865. 168 indexed citations
19.
Jeon, Ok‐Hee, et al.. (1999). Cloning, expression, and characterization of a cDNA encoding snake venom metalloprotease. IUBMB Life. 47(3). 417–425. 9 indexed citations
20.
Jeon, Ok‐Hee, et al.. (1995). An anticoagulant/fibrinolytic protease from Lumbricus rubellus.. BMB Reports. 28(2). 138–142. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026